Comparison of characteristics of patients with coronary heart disease receiving lipid-lowering therapy versus those not receiving such therapy*

      The aim of this study was to analyze characteristics associated with noncompliance with lipid-lowering guidelines among patients with coronary heart disease (CHD). More specifically, we analyzed failure to initiate lipid-lowering treatment in patients with CHD and low-density lipoprotein (LDL) cholesterol >130 mg/dl (3.37 mmol/L).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • NCEP Expert Panel
        Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
        • Sueta C.A.
        • Chowdhury M.
        • Boccuzzi S.J.
        • Smith Jr, S.C.
        • Alexander C.M.
        • Londhe A.
        • et al.
        Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease.
        Am J Cardiol. 1999; 83: 1303-1307